Markets:

Overview

News

Currencies

International

Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

3.630 -0.280 (-7.16%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

16 17 Next >

Nasdaq Down 1%; US Crude Oil Inventories Decline Last Week ↗

May 24, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.72% to 32,816.38 while the NASDAQ fell 1.12% to 12,419.97. The...

Via Benzinga

Enveric Biosciences Inc. (NASDAQ: ENVB) Leading the Way in Wednesday Trading Based on Percentage Gain

May 24, 2023

Via Investor Brand Network

Dow Falls Over 100 Points; Analog Devices Posts Upbeat Q2 Earnings ↗

May 24, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.44% to 32,908.94 while the NASDAQ fell...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 24, 2023

Via Benzinga

Enveric Stock Soars On Reception Of Notice Of Allowance For Patent Application For Its Psilocin Prodrug Designs ↗

May 24, 2023

Enveric Biosciences, Inc.

Via Benzinga

Why Is Enveric Biosciences (ENVB) Stock Up 120% Today? ↗

May 18, 2023

Enveric Biosciences’ Notice of Allowance for a therapeutic patent is bolstering ENVB stock, but investors should exercise caution.

Via InvestorPlace

Enveric Biosciences Receives Notice of Allowance From USPTO for C4-Carboxylic Acid-Substituted Tryptamine Derivatives for Next Generation Psilocin Prodrug

May 24, 2023

From Enveric Biosciences, Inc.

Via Business Wire

Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More ↗

May 23, 2023

Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History NY-based biotech platform Terran Biosciences announced the publication of an international PCT patent application...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 22, 2023

Via Benzinga

Enveric Releases Paper Detailing The Development Of Novel Psilocin Prodrugs For The Treatment Of Mental Health Disorders ↗

May 22, 2023

Enveric Biosciences, Inc. (NASDAQ: ENVB) has announced new research results detailing the development of novel psilocin prodrug derivatives targeting treatment of mental health disorders. A manuscript...

Via Benzinga

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 22, 2023

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

Via Benzinga

Enveric Biosciences Announces Manuscript Detailing the Development of Novel Psilocin Prodrugs for the Treatment of Anxiety and Other Mental Health Disorders

May 22, 2023

From Enveric Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 19, 2023

Via Benzinga

Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket ↗

May 19, 2023

Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of...

Via Benzinga

Enveric Biosciences to Participate in 2023 BIO International Convention in Boston

May 19, 2023

From Enveric Biosciences, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 19, 2023

It's time to start off the final day of the trading week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Dow Tumbles 150 Points; Alibaba Earnings Top Views ↗

May 18, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 150 points on Thursday. The Dow traded down 0.48% to 33,259.03 while the NASDAQ rose 0.63% to 12,579.41. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 18, 2023

Via Benzinga

Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 18, 2023

Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility.

Via Benzinga

Enveric Biosciences Inc. (NASDAQ: ENVB) is One of Thursday Morning’s Most Active Stocks

May 18, 2023

Via Investor Brand Network

Nasdaq Surges 100 Points; Walmart Raises Full-Year Outlook ↗

May 18, 2023

U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.09% to 33,451.95 while the NASDAQ rose 0.79% to 12,599.66. The S&P...

Via Benzinga

Enveric Biosciences (NASDAQ: ENVB) Obtains Notice of Allowance For a U.S. Patent Covering Its Innovative Psilocin Prodrug, EB-373

May 18, 2023

Enveric Biosciences, Inc. (NASDAQ: ENVB) is engaged as a biotechnology company, which focused on the research and development of innovative

Via Spotlight Growth

Topics Derivatives Intellectual Property

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 18, 2023

Via Benzinga

Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin ↗

May 18, 2023

Enveric Biosciences, Inc. (NASDAQ: ENVB) has received a notice of allowance from the United States Patent and Trademark Office for a patent application involving EB-373, th

Via Benzinga

Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin

May 18, 2023

From Enveric Biosciences, Inc.

Via Business Wire

Enveric Biosciences Q1 Net Loss Of $4.80M, More On Basic And Diluted Loss Per Share ↗

May 15, 2023

Enveric Biosciences, Inc. (NASDAQ: ENVB) released its corporate update and reported financial results for the first quarter of 2023 ending March 31, 2023.

Via Benzinga

Enveric Biosciences Reports First Quarter 2023 Financial Results and Operational Highlights

May 15, 2023

From Enveric Biosciences, Inc.

Via Business Wire

Enveric Biosciences Celebrates and Supports 2023 Mental Health Awareness Month

May 02, 2023

From Enveric Biosciences, Inc.

Via Business Wire

EXCLUSIVE: Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing Benefits ↗

April 20, 2023

Recently, at the Benzinga Psychedelic Capital Conference, leading experts from the biotech and pharmaceutical industry gathered to discuss the remarkable potential of psychedelics in medicine.

Via Benzinga

EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key' ↗

April 14, 2023

Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.